Summary The pattern of acquired mutations in the p53 tumour-suppressor gene is potentially useful for determining factors contributing to carcinogenesis in diverse populations differing in incidence and/or mortality from the disease. We previously reported differences in mutational patterns of the p53 gene in primary breast cancers from Midwest US Caucasian, African-American and Austrian women. Herein, we report 16 mutations in 27 primary breast cancers from Japanese women from Hirosaki, a population with a low incidence of breast cancer. The frequency of 59.3% of p53 mutations is the highest reported in breast cancers from a particular ethnic group thus far. A relatively high number of mutations (7/16) were heterozygous in at least some tumour cell clusters. Intergroup comparisons of the mutational pattern between this population and several other US, European and Japanese populations do not show any statistically significant differences. There were recurrent mutations at two sites, codon 273 (R-.H; three mutations), a common hotspot of mutations in breast and other cancers, and codon 183 (S-Stop; two mutations), a very rare location for p53 mutations. These mutations were shown to be independent and presumably not in the germ line. The highest frequency of p53 mutations raises the possibility that p53 mutagenesis is a predominant factor for breast cancer development in this low-risk Japanese group, whereas in other cohorts different mechanisms are likely to account for the higher proportion of breast cancer. Further studies are needed to confirm the present observations.
The pattern of acquired mutations in the same region of a particular gene in a particular type of cancer offers the possibility of detecting differences in mutagenic processes contributing to carcinogenesis in diverse populations differing in incidence and/or morbidity from the disease (Shields and Harris, 1991; Jones et al., 1991) . The mutational pattern of the p53 gene is a useful epidemiological tool as a 'mutagen test' (Sommer, 1990 ) because this gene is altered frequently in nearly all types of human cancer (reviewed in Harris and Hollstein, 1993) . In human breast cancers, the frequency of p53 gene mutations ranges from 20% to 40% in various US American, European and Japanese populations (Coles et al., 1992; Mazars et al., 1992; Sommer et al., 1992; Tsuda et al., 1993; Andersen et al., 1993; Thorlacius et al., 1993; Blaszyk et al., 1994; Hartmann et al., 1995a,b) .
We are investigating the pattern of p53 gene mutation in sporadic breast cancer in racially and geographically diverse populations with different risks for this disease. We assume that the patterns of mutation in high-risk populations reflect the superimposition of a pattern caused by a unique or enhanced exposure to a particular environmental toxin(s) upon an intrinsic (endogenous) pattern of mutation characteristic of low-risk groups. We have shown that the pattern of p53 gene mutations in primary breast cancers in a white, largely rural Midwestern US population (Sommer et al., 1992; Saitoh et al., 1994) and in a population from Graz, Austria (Hartmann et al., 1995a) , differs significantly from the pattern present in African -American women from Detroit and from the patterns in Scottish (Coles et al., 1992) and French (Mazars et al., 1992) women. The major differences among these populations are: a predominance of transversions, particularly G:C-+T:A transversions in the Scottish population; a high frequency of microdeletions in the rural white US population; a high frequency of A:T-+T:A transversions in the Austrian population; and a high frequency of transitions, particularly A:T-+G:C transitions, in the African-American population. The implication is that different endogenous and/or exogenous factors contribute to breast carcinogenesis to different extents in these populations.
Japanese women have a very low breast cancer risk with age-adjusted incidence and mortality rates per 100 000 per year (30-74 years of age) of 54.4 and 12.6 respectively (Coleman et al., 1993) . For US American and Scottish women these numbers are 3-4 times higher (USA, 183.2 and 46.1; and Scotland, 132.1 and 57.5; Coleman et al., 1993; Boring et al., 1993) . To investigate the frequency and pattern of p53 mutations in a population with a low-risk of the disease and to compare the results with the mutational patterns of the high-risk groups studied, 27 unselected primary breast cancers from Japanese women living in Hirosaki, Japan, were analysed. Sixteen mutations (59.3%) were found. This is the highest frequency of mutation in the p53 gene in breast cancers reported to date.
Materials and methods
Human tissue samples Twenty-seven primary breast cancers collected consecutively from the Department of Surgery in Hirosaki, Japan, were analysed. Samples were snap frozen in liquid nitrogen, shipped to Rochester, MN, USA, on dry ice, and stored at -70°C until the time of analysis. Touch preparations from the partially thawing cut surface of frozen tissue were made as described previously (Kovach et al., 1991) . Small clusters of pure tumour cells adherent to the slide were stained by brief dipping in a methylene blue-toluidine blue solution. After rinsing in tap water, clusters of 30 -100 malignant cells were lifted from the slide on the tip (0.1 mm in diameter) of a hand-held glass pipette. The clusters were placed in 5 MI of 0.5% dextrose in water in a 0.6 ml sterile microfuge tube and processed for amplification or stored frozen at -70°C.
Amplification
Cells from frozen samples were lysed by the addition of proteinase K in a solution of sodium dodecyl sulphate (SDS). The p53 gene was amplified in three segments by nested amplification as described previously (Sommer et al., 1992; Saitoh et al., 1994 (Sarkar et al., 1992) . In addition, ddF detected all 25 mutations among 73 breast cancers of our white Midwestern population found by direct genomic sequencing of the p53 gene (Blaszyk et al., 1995) .
Sequencing
All regions of abnormality detected by ddF were sequenced in both directions using genomic amplification with transcript sequencing (GAWTS; Stoflet et al., 1988; Sommer and Vielhaber, 1994) and sequencing primers as previously described (Sommer et al., 1992; Saitoh et al., 1994 cycles consisting of 1 min at 98°C, 2 min at 62°C and 4 min at 70°C for D2S123 and (AR) and of 1 min at 98°C and 5 min at 70°C for all other repeats with a final extension of 10 min at 70°C. The PCR primer sequences are available upon request. The PCR products were electrophoresed through 6% polyacrylamide gels containing 7.7 M urea for 3 h. After electrophoresis the gels were dried and exposed to X-ray film. Eleven tumours were screened for every repeat (the five The following polymorphisms within the p53 gene were screened either by PCR (CA-repeat) or by direct sequencing as described above: a dinucleotide repeat polymorphism (Jones and Nakamura, 1992) , a C/G polymorphism in intron 2 37 bp 3' from exon 2 (Pignon et al., 1994) Highly polymorphic repeats: 1 13T, 1 14T, lI5T are different from'each other in three repeats: 202T is different in three repeats from 1 lOT. Polymorphisms within the p53 gene: insertion polymorphism in intron 3 and the polymorphisms in intron 2 and intron 6 are not informative; polymorphism at amino acid 72 is not informative for 1 lOT and 202T; showed independence of mutation for 1 13T, 1 14T, 11ST and showed that analyses is a high frequency of heterozygous rather than hemizygous mutations in this cohort (Table I) . Seven of 16 mutations were heterozygous, i.e. had equal representation of wild-type and mutant sequence on genomic analysis. This high frequency of heterozygosity was statistically significant (P< 0.05) when compared with all non-Japanese populations analysed by us (Saitoh et al., 1994; Blaszyk et al., 1994; Hartmann et al., 1995a) . This observation raises the possibility that Japanese women have greater genomic stability, at least with respect to allelic deletion of the p53 gene, than various Western populations.
Clustering of p53 mutations
In the present sample, independent recurrent mutations were found at two sites (Table III) . Three independent missense mutations occurred at amino acid 273 (G:C-.A:T). This is a known mutational hotspot occurring at a CpG site coding for an amino acid that is conserved in all known p53 sequences (Soussi et al., 1990) . This degree of conservation extends over 1.6 billion years of evolutionary divergence. In a database of 1965 p53 mutations (De Vries et al., 1996) , this mutation occurs 112 times (7.3%). Hsu et al., 1991) ; and C:G-+T:A transitions and CC:GG-TT:AA tandem dipyrimidine transitions and multiple mutations, UV-B radiation and squamous and basal cell carcinomas of the sun-exposed skin (Brash et al., 1991; Moles et al., 1993 , and an abundance of A:T-+T:A transversions in patients from Graz, Austria (Hartmann et al., 1995a) .
The Hirosaki population described in this report has a pattern of mutation that does not have a predominant type of mutation compared with several high-risk groups. The pattern seen could reflect mutagenic exposure similar to other groups as modified by genetic factors affecting processes such as DNA repair and/or adduct formation. Alternatively, the pattern in Hirosaki patients could reflect the baseline (endogenous) pattern unmodified by exogenous mutagens. In high-risk populations, a dominant mutagen or mutagens may skew the endogenous pattern in ways that the resulting patterns among high-risk groups differ more from each other than from the endogenous pattern in low-risk (non-mutagen exposed) groups. It will be difficult but important to distinguish among these alternatives. Analysis of the pattern of p53 mutations in breast cancers in other low-risk populations is needed to determine if a single pattern is characteristic of these groups. We are studying Japanese breast cancer patients who are migrants to the US to investigate the influence of a different lifestyle on the pattern of p53 mutation.
Immunohistochemistry
There are numerous reports of correlations between immunohistochemically detectable p53 expression in the nucleus of malignant cells and the presence of a missense mutation in the p53 gene and between absence of p53 expression and absence of p53 mutation or presence of a null mutation (nonsense, frameshift and splice site mutation; reviewed in Harris and Hollstein, 1993) . Our previous studies of US Caucasian (Saitoh et al., 1994) , US African-American and Austrian (Hartmann et al., 1995a) cohorts of breast cancers showed a significant relationship between nuclear expression of the p53 antigen and the presence of a 'missense-type' mutation (missense and inframe microdeletion/insertion). In the Hirosaki patients, although six of eight tumours with missense mutations reacted with PAb 1801, an anti-p53 antibody that consistently stains cells with missense p53 mutations (JM Cunningham, personal communication), three tumours with the same missense change at codon 273 had different staining patterns. One stained only with PAb 1801, one with both PAb 1801 and PAb 240 and one did not stain, supporting the clustering of three identical mutations at this particular codon, which is unlikely to be due to technical artefact. As we have found in studies of p53 mutations in other populations, the antibody PAb240 frequently reacts with cells hemizygous or heterozygous for p53 gene null mutations (JM Cunningham, personal communication). None of the 11 tumours in which we did not detect a p53 gene mutation stained with PAbl801 or PAb421, but two stained with PAb240. The basis of these aberrant findings remains unclear, but they raise the possibility of a biological difference among tumours in this population that modifies p53 expression compared with other cohorts previously studied by us with identical methodology. Abbreviations ddF, dideoxy fingerprinting; AR, androgen receptor gene; DM, myotonic dystrophy gene; aa, amino acid.
